Literature DB >> 11473058

Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.

R A Kowluru1, J Tang, T S Kern.   

Abstract

Antioxidants were administered to diabetic rats and experimentally galactosemic rats to evaluate the ability of these agents to inhibit the development of diabetic retinopathy. Alloxan diabetic rats and nondiabetic rats that were fed 30% galactose randomly received standard diets or the diets supplemented with ascorbic acid and alpha-tocopherol (vitamins C+E diet) or a more comprehensive mixture of antioxidants (multi-antioxidant diet), including Trolox, alpha-tocopherol, N-acetyl cysteine, ascorbic acid, beta-carotene, and selenium. Diabetes or galactose feeding of at least 12 months resulted in pericyte loss, acellular capillaries, and basement membrane thickening. Compared with diabetic controls, the development of acellular capillaries was inhibited by 50% (P < 0.05) in diabetic rats that received supplemental vitamins C+E, and the number of pericyte ghosts tended to be reduced. The vitamins C+E supplement had no beneficial effect in galactosemic rats, but these rats consumed only approximately half as much of the antioxidants as the diabetic rats. The multi-antioxidant diet significantly inhibited ( approximately 55-65%) formation of both pericyte ghosts and acellular capillaries in diabetic rats and galactosemic rats (P < 0.05 vs. controls), without affecting the severity of hyperglycemia. Parameters of retinal oxidative stress, protein kinase C activity, and nitric oxides remained elevated for at least 1 year of hyperglycemia, and these abnormalities were normalized by multi-antioxidant therapy. Thus, long-term administration of antioxidants can inhibit the development of the early stages of diabetic retinopathy, and the mechanism by which this action occurs warrants further investigation. Supplementation with antioxidants can offer an achievable and inexpensive adjunct therapy to help inhibit the development of retinopathy in diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473058     DOI: 10.2337/diabetes.50.8.1938

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  155 in total

1.  Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?

Authors:  Renu A Kowluru; Qing Zhong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

2.  Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability.

Authors:  Yunpeng Du; Megan Cramer; Chieh Allen Lee; Jie Tang; Arivalagan Muthusamy; David A Antonetti; Hui Jin; Krzysztof Palczewski; Timothy S Kern
Journal:  FASEB J       Date:  2015-02-09       Impact factor: 5.191

3.  Different effects of low- and high-dose insulin on ROS production and VEGF expression in bovine retinal microvascular endothelial cells in the presence of high glucose.

Authors:  Haixiang Wu; Chunhui Jiang; Dekang Gan; Yujie Liao; Hui Ren; Zhongcui Sun; Meng Zhang; Gezhi Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

4.  Mitochondrial biogenesis and the development of diabetic retinopathy.

Authors:  Julia M Santos; Shikha Tewari; Andrew F X Goldberg; Renu A Kowluru
Journal:  Free Radic Biol Med       Date:  2011-08-25       Impact factor: 7.376

5.  The stress response protein REDD1 promotes diabetes-induced oxidative stress in the retina by Keap1-independent Nrf2 degradation.

Authors:  William P Miller; Siddharth Sunilkumar; Joseph F Giordano; Allyson L Toro; Alistair J Barber; Michael D Dennis
Journal:  J Biol Chem       Date:  2020-04-15       Impact factor: 5.157

Review 6.  Do photoreceptor cells cause the development of retinal vascular disease?

Authors:  Timothy S Kern
Journal:  Vision Res       Date:  2017-05-08       Impact factor: 1.886

7.  Impaired transport of mitochondrial transcription factor A (TFAM) and the metabolic memory phenomenon associated with the progression of diabetic retinopathy.

Authors:  Julia M Santos; Renu A Kowluru
Journal:  Diabetes Metab Res Rev       Date:  2013-03       Impact factor: 4.876

8.  Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression.

Authors:  Sally A Madsen-Bouterse; Ghulam Mohammad; Mamta Kanwar; Renu A Kowluru
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

9.  Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  Lab Invest       Date:  2010-05-17       Impact factor: 5.662

10.  Increased oxidative stress in diabetes regulates activation of a small molecular weight G-protein, H-Ras, in the retina.

Authors:  Vibhuti Kowluru; Renu A Kowluru
Journal:  Mol Vis       Date:  2007-04-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.